Cns Pharmaceuticals, Inc. Overview
Cns Pharmaceuticals, Inc. filed as a Domestic Corporation in the State of Nevada on Thursday, July 27, 2017 and is approximately seven years old, according to public records filed with Nevada Secretary of State.
Sponsored
Learn More
D&B Reports Available for
Cns Pharmaceuticals, Inc.
Network Visualizer
Advertisements
Key People
Who own Cns Pharmaceuticals, Inc.
Name | |
---|---|
Chris Downs |
CFO
Director
Chief Financial Officer
Director, Chief Fina
|
John Climaco |
NonDir
NonPres
Director
Chief Executive Officer
Director, Chief Exec
|
Donald Picker |
NonDir
Director
|
Jerzy Gumulka |
NonDir
Director
|
Matthew J. Lourie 1 |
NonSec
NonTreas
NonDir
|
Carl Evans |
Director
|
Jeffry Keyes |
Director
|
Andrzej Andraczke |
Director
|
Faith Charles |
Director
|
Bettina Cockroft |
Director
|
J. George Gumulka |
Director
|
Showing 8 records out of 11
Known Addresses for Cns Pharmaceuticals, Inc.
Corporate Filings for Cns Pharmaceuticals, Inc.
Nevada Secretary of State
Filing Type: | Domestic Corporation |
---|---|
Status: | Active |
State: | Nevada |
State ID: | E0354342017-0 |
Date Filed: | Thursday, July 27, 2017 |
Texas Secretary of State
Filing Type: | Foreign For-Profit Corporation |
---|---|
Status: | Active In existence |
State: | Texas |
State ID: | 802903183 |
Date Filed: | Tuesday, January 9, 2018 |
Corporate Notes
Source | Date | Type | Note |
---|---|---|---|
7/27/2017 | Articles of Incorporation | Initial Stock Value: Par Value Shares: 20,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ $20,000.00 | |
10/17/2017 | Initial List | ||
1/9/2018 | Application for Registration | ||
7/5/2018 | Annual List | ||
7/13/2018 | Registered Agent Change | ||
10/24/2018 | Amended & Restated Articles | Previous Stock Value: Par Value Shares: 20,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 20,000.00New Stock Value: Par Value Shares: 75,000,000 Value: $ 0.001 No Par Value Shares: 0 ----------------------------------------------------------------- Total Authorized Capital: $ 75,000.00 | |
12/31/2019 | Public Information Report (PIR) | ||
12/31/2020 | Public Information Report (PIR) | ||
12/31/2020 | Public Information Report (PIR) | ||
12/31/2021 | Public Information Report (PIR) | ||
12/31/2022 | Public Information Report (PIR) | ||
12/31/2022 | Public Information Report (PIR) | ||
12/31/2023 | Public Information Report (PIR) | ||
12/31/2023 | Public Information Report (PIR) |
Advertisements
Sources
Nevada Secretary of State
Data last refreshed on Wednesday, May 8, 2019
Data last refreshed on Wednesday, May 8, 2019
Texas Secretary of State
Data last refreshed on Saturday, March 2, 2024
Data last refreshed on Saturday, March 2, 2024
What next?
Follow
Receive an email notification when changes occur for Cns Pharmaceuticals, Inc..
Notifications include:
- New company roles
- Change in active status
- Location updates
- New connections
Follow
Create Account
Create a free account to access additional details for Cns Pharmaceuticals, Inc. and other profiles that you visit
Benefits include:
- Access to more records
- Full screen network visualizer
- Follow profiles
- See how people are connected
Advertisements
2
Known Addresses
These addresses are known to be associated with Cns Pharmaceuticals, Inc. however they may be inactive or mailing addresses only. Please verify address for mailing or other purposes.
Wiki
2
Corporate Records